APA način citiranja

Lara, P. N., Moon, J., Hesketh, P. J., Redman, M. W., Williamson, S. K., Akerley, W. L., . . . Gandara, D. R. (2015). SWOG 0709: Randomized Phase II Trial of Erlotinib vs. Erlotinib plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay. J Thorac Oncol.

Čikaški stil citiranja

Lara, Primo N., James Moon, Paul J. Hesketh, Mary W. Redman, Stephen K. Williamson, Wallace L. Akerley, Fred R. Hirsch, Philip C. Mack, i David R. Gandara. "SWOG 0709: Randomized Phase II Trial of Erlotinib Vs. Erlotinib Plus Carboplatin/Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer and Impaired Performance Status As Selected By a Serum Proteomics Assay." J Thorac Oncol 2015.

MLA način citiranja

Lara, Primo N., et al. "SWOG 0709: Randomized Phase II Trial of Erlotinib Vs. Erlotinib Plus Carboplatin/Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer and Impaired Performance Status As Selected By a Serum Proteomics Assay." J Thorac Oncol 2015.